DGAP-News

AlzChem AG is planning an IPO in Frankfurt

DGAP-News: AlzChem AG / Key word(s): IPO
AlzChem AG is planning an IPO in Frankfurt

16.01.2017 / 07:30
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

NOT FOR DISTRIBUTION IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA.

CORPORATE NEWS


AlzChem AG is planning an IPO in Frankfurt

- AlzChem AG, a vertically integrated specialty chemicals producer with
leading positions in selected niche markets, is planning an initial
public offering (IPO) in the regulated market (Prime Standard) of the
Frankfurt Stock Exchange.

- Strong competitive positioning with market entry barriers due to a
vertically integrated manufacturing system ("Verbund system"),
trademark and patent rights and other intellectual property from
extensive research and development activities as well as complex
regulatory requirements.

- High potential for future growth by consistently aligning products with
external growth drivers such as global population growth, healthy aging
and energy efficiency.

- The planned proceeds of approximately EUR 40 to 50 million from the
capital increase as part of the IPO are intended to be invested to a
large extent in the construction of a new production facility for the
specialty chemical product CreAMINO at the Trostberg site.


Trostberg, January 16, 2017 - AlzChem AG (together with its subsidiaries
hereinafter "AlzChem") plans an IPO on the regulated market (Prime
Standard) of the Frankfurt Stock Exchange in the first half of 2017.
AlzChem is headquartered in Trostberg in the "Bavarian Chemical
Triangle" (ChemDelta Bavaria). As a vertically integrated chemical company
with 1,480 employees, AlzChem produces and markets chemical products from
the calcium carbide / calcium cyanamide value chain (NCN chain) for
diversified markets. These products with a typical nitrogen-carbon-nitrogen
bond are used in a variety of industries. Serving customers worldwide,
AlzChem has four production sites in Germany, a carbide plant in Sweden, a
sales subsidiary in the US and a Chinese subsidiary for raw material
purchase and Asian sales.

"We are taking the lead in selected niche markets, including markets for
feed additives and food supplements, which have significant growth
potential. We feel we are very well positioned for future profitable
growth. Besides vertical integration, our clear focus is on research and
development. Furthermore, we are protected by high market entry barriers,"